Fingerprint
Dive into the research topics of 'Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway
Nozomu Yanaihara, Yuki Yoshino, Daito Noguchi, Junya Tabata, Masataka Takenaka, Yasushi Iida, Misato Saito, Satoshi Yanagida, Masami Iwamoto, Takako Kiyokawa, Natsuko Chiba, Aikou Okamoto
Research output: Contribution to journal › Article › peer-review